QuietMIND Foundation (QMF) is a public non-profit applied neuroscience research foundation and consultation organization. Our mission: improving global healthcare and healthcare education by providing models and methods that enhance self advocacy and social maturity. QMF has studied and advocates the use of functional medicine, photobiomodulation and neurofeedback training and provides home-based equipment and remote consultation. QMF's consultats includes internationally recognized, highly-trained, professionals drawn from the fields of biofeedback and neuropsychology, neurophysiology, functional medicine, neuropsychiatry, neuroscience research, organizational consulting, and healthcare law.
We also rely on the skills of staff and professionally trained volunteers to design and deliver our marketing and advertising campaigns, and perform some of our administrative functions. We have a national and worldwide network of professionals with whom we consult.
We train licensed professionals and graduate level interns to conduct applied clinical research including grant proposal development, continuing education program design and delivery.
We also rely on the skills of staff and professionally trained volunteers to design and deliver our marketing and advertising campaigns, and perform some of our administrative functions. We have a national and worldwide network of professionals with whom we consult.
We train licensed professionals and graduate level interns to conduct applied clinical research including grant proposal development, continuing education program design and delivery.
|
|
Marvin H. Berman, Ph.D., C.B.T.,
Founder & President
Dr. Berman earned his Master’s and PhD in Psychoeducational Processes from Temple University, where he studied group and organizational behavior. He obtained certification in Bioenergetic Analysis at the Philadelphia Institute for Bioenergetic Analysis in 1983. He has participated in extensive post-graduate training and in Systems-Centered Therapy, and the Feldenkrais Method. He was certified in EEG biofeedback in 2003. Dr. Berman is a recognized thought leader in the application of photobiomodulation and EEG biofeedback and related technologies to better understand neurodegenerative, neurodevelopmental and neuropsychiatric disorders. Dr. Berman consults with academic neuroscience researchers, healthcare providers, and integrative healthcare clinics on the application of photobiomodulation and neurofeedback.
Trent W Nichols MD
Medical Director, Quietmind Foundation
Trent W Nichols MD is a Northwestern University Med School grad and Postdoc Internal Med and Gastroenterology. His research has been in pharmaceutical clinical trials, nutraceuticals with "Optimal Digestive Health" a book for the public and 2 textbooks.
He pioneered the development of moderate magnetic field therapy involving zero point and 0.5T magnetic therapy for neurodegenerative disorders. He joined QMF to advance the development of self-administered applications of his pioneering work in noninvasive therapeutics. Dr. Nichols is also the Chief Medical Officer for the International Cancer Association for Education and Research (ICARE).
He pioneered the development of moderate magnetic field therapy involving zero point and 0.5T magnetic therapy for neurodegenerative disorders. He joined QMF to advance the development of self-administered applications of his pioneering work in noninvasive therapeutics. Dr. Nichols is also the Chief Medical Officer for the International Cancer Association for Education and Research (ICARE).
Adam Stamm
Assistant Executive Director
Adam Stamm is an alumni of Albright College. He has worked with Quietmind Foundation since 2019. Adam begin his involvement at Quietmind Foundation as a volunteer. He met Marvin Berman and learned about the Quietmind Foundation while traveling from Philadelphia, PA to Denver on a plane. He was fascinated by the concepts and research and couldn't wait to get involved.
Adam is responsible for helping manage various administrative tasks such as website updates, social media accounts, and QMF Newsletters. As a marketing and communications professional, Adam has helped to promote and organize research studies around photobiomodulation for QMF.
Paul Chazot, PhD, Scientific Advisory Board Member, Dept. of Biosciences, Durham University, Durham UK.
Dr. Chazot has produced a significant body of research on the mechanisms and clinical application of 1068-1080nm pulsed photobiomodulation. He has been the basic science mentor for QMF and leading advocate for the exploration of PBM as a potential disease-modifying intervention strategy, who with Dr. Gordon Dougal MD, BSEE have been the driving force behind the development of the Cognitolite technology. Quietmind Fdn. was fortunate to be chosen to conduct the first human clinical trials using the 1070nm PBMT device in 2009 and over the next 15 years, now with our study partners at Baylor Research Institute in Temple, TX
Allan Lundy, Ph.D., IRB Chairman
Dr Lundy earned his PhD in Social Psychology from Harvard University in 1981. Between 1992 and 2003 he was on the faculty of the Department of Psychiatry at Jefferson Medical College. During that time, he published 32 articles and book chapters. In his last six years at Jefferson he was Principal Investigator on NIH and other grants totaling over two million dollars. Since 2003 he has been an independent consultant in research methods and statistical analysis.
Dr. Chazot has produced a significant body of research on the mechanisms and clinical application of 1068-1080nm pulsed photobiomodulation. He has been the basic science mentor for QMF and leading advocate for the exploration of PBM as a potential disease-modifying intervention strategy, who with Dr. Gordon Dougal MD, BSEE have been the driving force behind the development of the Cognitolite technology. Quietmind Fdn. was fortunate to be chosen to conduct the first human clinical trials using the 1070nm PBMT device in 2009 and over the next 15 years, now with our study partners at Baylor Research Institute in Temple, TX
Allan Lundy, Ph.D., IRB Chairman
Dr Lundy earned his PhD in Social Psychology from Harvard University in 1981. Between 1992 and 2003 he was on the faculty of the Department of Psychiatry at Jefferson Medical College. During that time, he published 32 articles and book chapters. In his last six years at Jefferson he was Principal Investigator on NIH and other grants totaling over two million dollars. Since 2003 he has been an independent consultant in research methods and statistical analysis.
Quietmind Foundation
Philadelphia Office
Adam Stamm
Asst Executive Director
1819 S Hicks St
Philadelphia PA 19145
Please send mail to:
New Jersey Office (MAIN)
145 La Quinta Dr.
Egg Harbor, NJ 08234
Minnesota Office
Jeffey Leighton, PhD
545 2nd St, Suite 532
Excelsior, MN 55331
Adam Stamm
Asst Executive Director
1819 S Hicks St
Philadelphia PA 19145
Please send mail to:
New Jersey Office (MAIN)
145 La Quinta Dr.
Egg Harbor, NJ 08234
Minnesota Office
Jeffey Leighton, PhD
545 2nd St, Suite 532
Excelsior, MN 55331
Support Quietmind Foundation's ongoing research!
Looking to help ensure our innovative clinical research continues? Please donate today!
Quietmind Fdn is an IRS-registered 501c3 nonprofit charity, all donations are fully tax deductible,
Quietmind Fdn is an IRS-registered 501c3 nonprofit charity, all donations are fully tax deductible,
